![Prevalence of overuse of short-acting beta-2 agonists (SABA) and associated factors among patients with asthma in Germany | Respiratory Research | Full Text Prevalence of overuse of short-acting beta-2 agonists (SABA) and associated factors among patients with asthma in Germany | Respiratory Research | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12931-021-01701-3/MediaObjects/12931_2021_1701_Fig1_HTML.png)
Prevalence of overuse of short-acting beta-2 agonists (SABA) and associated factors among patients with asthma in Germany | Respiratory Research | Full Text
![Drugs affecting the respiratory system. Main disorders of the respiratory system are 1.Bronchial asthma. 2.Chronic obstructive pulmonary disease (COPD). - ppt download Drugs affecting the respiratory system. Main disorders of the respiratory system are 1.Bronchial asthma. 2.Chronic obstructive pulmonary disease (COPD). - ppt download](https://images.slideplayer.com/32/10015656/slides/slide_20.jpg)
Drugs affecting the respiratory system. Main disorders of the respiratory system are 1.Bronchial asthma. 2.Chronic obstructive pulmonary disease (COPD). - ppt download
![Asthma control | Measures to Identify and Track Racial Disparities in Childhood Asthma | Asthma | NCEH Asthma control | Measures to Identify and Track Racial Disparities in Childhood Asthma | Asthma | NCEH](https://www.cdc.gov/asthma/asthma_disparities/images/control_for_each_component.jpg)
Asthma control | Measures to Identify and Track Racial Disparities in Childhood Asthma | Asthma | NCEH
![Overuse of short-acting β2-agonists in asthma is associated with increased risk of exacerbation and mortality: a nationwide cohort study of the global SABINA programme | European Respiratory Society Overuse of short-acting β2-agonists in asthma is associated with increased risk of exacerbation and mortality: a nationwide cohort study of the global SABINA programme | European Respiratory Society](https://erj.ersjournals.com/content/erj/55/4/1901872/F2.large.jpg)
Overuse of short-acting β2-agonists in asthma is associated with increased risk of exacerbation and mortality: a nationwide cohort study of the global SABINA programme | European Respiratory Society
![New approach to intermittent and mild asthma therapy: evolution or revolution in the GINA guidelines? | Clinical and Translational Allergy | Full Text New approach to intermittent and mild asthma therapy: evolution or revolution in the GINA guidelines? | Clinical and Translational Allergy | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13601-020-00316-z/MediaObjects/13601_2020_316_Fig4_HTML.png)
New approach to intermittent and mild asthma therapy: evolution or revolution in the GINA guidelines? | Clinical and Translational Allergy | Full Text
![Table 1 from Formoterol versus short-acting beta-agonists as relief medication for adults and children with asthma. | Semantic Scholar Table 1 from Formoterol versus short-acting beta-agonists as relief medication for adults and children with asthma. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/c6b8d0ee7b688da71e94900d540176f65e3c1d22/54-Table1-1.png)
Table 1 from Formoterol versus short-acting beta-agonists as relief medication for adults and children with asthma. | Semantic Scholar
![Sports | Free Full-Text | Overuse of Short-Acting Beta-2 Agonists (SABAs) in Elite Athletes: Hypotheses to Explain It Sports | Free Full-Text | Overuse of Short-Acting Beta-2 Agonists (SABAs) in Elite Athletes: Hypotheses to Explain It](https://www.mdpi.com/sports/sports-10-00036/article_deploy/html/images/sports-10-00036-g001.png)
Sports | Free Full-Text | Overuse of Short-Acting Beta-2 Agonists (SABAs) in Elite Athletes: Hypotheses to Explain It
![Short-acting beta agonist (SABA) medication use overall and by SABA... | Download Scientific Diagram Short-acting beta agonist (SABA) medication use overall and by SABA... | Download Scientific Diagram](https://www.researchgate.net/publication/335188173/figure/tbl1/AS:792155920547841@1565876097453/Short-acting-beta-agonist-SABA-medication-use-overall-and-by-SABA-overuse-versus-SABA.png)
Short-acting beta agonist (SABA) medication use overall and by SABA... | Download Scientific Diagram
![Debate on long-acting β agonists for asthma: they think it's all over - The Lancet Respiratory Medicine Debate on long-acting β agonists for asthma: they think it's all over - The Lancet Respiratory Medicine](https://www.thelancet.com/cms/attachment/a4eb7df3-c49d-42a7-ab98-80ea9b2ef173/gr1_lrg.jpg)
Debate on long-acting β agonists for asthma: they think it's all over - The Lancet Respiratory Medicine
![Is there a rationale and role for long-acting anticholinergic bronchodilators in asthma? | npj Primary Care Respiratory Medicine Is there a rationale and role for long-acting anticholinergic bronchodilators in asthma? | npj Primary Care Respiratory Medicine](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fnpjpcrm.2014.23/MediaObjects/41533_2014_Article_BFnpjpcrm201423_Fig1_HTML.jpg)
Is there a rationale and role for long-acting anticholinergic bronchodilators in asthma? | npj Primary Care Respiratory Medicine
![Overuse of short-acting β2-agonists in asthma is associated with increased risk of exacerbation and mortality: a nationwide cohort study of the global SABINA programme | European Respiratory Society Overuse of short-acting β2-agonists in asthma is associated with increased risk of exacerbation and mortality: a nationwide cohort study of the global SABINA programme | European Respiratory Society](https://erj.ersjournals.com/content/erj/55/4/1901872/F5.large.jpg?width=800&height=600&carousel=1)
Overuse of short-acting β2-agonists in asthma is associated with increased risk of exacerbation and mortality: a nationwide cohort study of the global SABINA programme | European Respiratory Society
![Pro and con for using SABA and ICS-FORM as relivers. SABA short acting... | Download Scientific Diagram Pro and con for using SABA and ICS-FORM as relivers. SABA short acting... | Download Scientific Diagram](https://www.researchgate.net/publication/341880118/figure/fig2/AS:899514009415681@1591472260182/Pro-and-con-for-using-SABA-and-ICS-FORM-as-relivers-SABA-short-acting-beta2-agonist-ICS.png)